Home / team-member / Matthew J. Jennings

Matthew J. Jennings

Operating Partner
  • Investment Status:
  • Mr. Jennings has been affiliated with Kohlberg since 2011 and was named an Operating Partner in 2020.

    He is currently Chairman of PCI Pharma Services, Spinal Elements, Trinity Life Sciences and Worldwide Clinical Trials, Executive Chairman of Cadence and a member of the board of directors of Nelipak. Previously, he served as Chairman, CEO & President of Phillips- Medisize and as a member of the board of Spectrum Plastics Group and e+Cancer-Care, all past Kohlberg portfolio companies. He is responsible for investment thesis development, company diligence and portfolio company operations management in the Pharmaceutical/Medical Products & Services sector. Prior to his affiliation with Kohlberg, his senior executive positions included CEO of CoJen Pharma (renamed Covis Pharma); President, North America for Teleflex Incorporated; President & CEO of BioEnterprise; and various senior-level management positions at Cardinal Health, Allegiance Corp., and Baxter International.

    Mr. Jennings received an M.B.A. from Michigan State University’s Eli Broad College of Business and a B.S. from Miami (Ohio) University.